OpenVSafe by OpenVAERS
Search V-safe

A6Q-15840-32264

3 vaccinations 3 coded responses 27 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
981 / WA
Registered
2020-12-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Registered in v-safe
  2. 2020-12-29
    Dose 1 — Moderna
  3. 2020-12-29
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · Headache
    Adult check-in
  5. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  6. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-05
    Survey response — day 7, dose 1
    MedDRA: Injection site urticaria, Self-medication, Vaccination site reaction — Feeling: Good · Site: Swelling, Itching
    Free text: Large urticarial plaque at injection site approximately 4 to 5 cm. It is responsive to antihistamines. Clinically consistent with delayed localized injection reaction
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-12
    Survey response — day 14, dose 1
    MedDRA: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Medical counselling, Office visit, Type IV hypersensitivity reaction — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Significant localized injection site reaction onset at day seven. Marked swelling and pain. Area of erythema and swelling approximately 20 x 10 cm lasting several days. Findings consistent with type for delayed hypersensitivity localized reaction. · Healthcare visit (other): Saw a colleague who is an allergist to confirm my suspicion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-12
    Report sent to call center — day 14, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-01-19
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-01-26
    Dose 2 — Moderna
  15. 2021-01-26
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  17. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  18. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  19. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-02
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-02-09
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-16
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-23
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-25
  26. 2021-02-27
  27. 2021-03-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-03-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-04-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2021-07-27
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-11-05
    Dose 3 — Moderna
  32. 2022-01-26
    Survey response — 12 months, dose 2
    MedDRA: Chest discomfort, Headache, Myalgia, Nausea, Pyrexia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Post vaccine fever, myalgias, nausea, severe headache lasting 36 hrs. 3 days after the booster I Developed chest pressure which lasted a week
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-26
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  34. 2022-01-27
  35. 2022-05-06
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-11-05
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna
22021-01-26Moderna
32021-11-05Moderna No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-05

Systemic reaction (other): Large urticarial plaque at injection site approximately 4 to 5 cm. It is responsive to antihistamines. Clinically consistent with delayed localized injection reaction

Release 1 — day 14, dose 1

2021-01-12

Symptoms: Significant localized injection site reaction onset at day seven. Marked swelling and pain. Area of erythema and swelling approximately 20 x 10 cm lasting several days. Findings consistent with type for delayed hypersensitivity localized reaction.
Healthcare visit (other): Saw a colleague who is an allergist to confirm my suspicion

Release 11 — 12 months, dose 2

2022-01-26

Symptoms: Post vaccine fever, myalgias, nausea, severe headache lasting 36 hrs. 3 days after the booster I Developed chest pressure which lasted a week

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical counselling ✓ · ✓
HCVOOffice visit ○ ✓ ○
SDChest discomfort · · ✓
SDHeadache · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site reaction ○ ✓ ○
SDInjection site swelling ✓ ✓ ✓
SDMyalgia · · ✓
SDNausea · · ✓
SDPyrexia · · ✓
SDType IV hypersensitivity reaction ✓ ✓ ✓
SROInjection site urticaria ✓ ✓ ✓
SROSelf-medication ✓ ✓ ✓
SROVaccination site reaction ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release